Bango Reports Strong Recurring Revenue Growth and Positive Cash EBITDA in FY25 Results

My read is simple: this is the investment case. If Bango can keep converting new large customers and then expand within them, the DVM becomes more valuable over time. That network effect is not guaranteed, but the latest numbers suggest it is moving in the right direction.

Bango payments revenue fell, but management is deliberately sacrificing weaker sales

The weak spot is the payments segment, where revenue dropped 15% to $30.0 million. On the face of it, that looks ugly. But management has been quite clear that it is intentionally moving away from legacy low-margin payment routes.

That distinction matters. Lower revenue is not always bad if the revenue being lost is low quality and contributes little profit. Bango says core payments revenue, excluding those low-margin routes and one-off fees, grew by about 5% year-on-year and represents more than 80% of the portfolio’s revenue.

So this looks like a conscious clean-up rather than a business falling apart. Even so, it does create a near-term drag on headline revenue, and investors should expect that trade-off to continue while the company prioritises margin over volume.

Gross margin expansion and positive Cash EBITDA show a better quality business

The most encouraging financial improvement in FY25 was margin. Gross margin increased by more than 600 basis points to 84%, up from 78%. A basis point is one hundredth of a percentage point, so that is a chunky improvement.

Adjusted EBITDA rose 7% to $16.4 million, while Cash EBITDA improved to $2.3 million from a loss of $0.2 million. Cash EBITDA is Adjusted EBITDA minus capital expenditure, so it is a rough way of showing whether the business is generating cash after ongoing investment.

That positive Cash EBITDA figure is important because it suggests Bango is getting closer to self-funding growth. It also supports the argument that the DVM is becoming a scalable platform rather than a perpetual cash drain.

Cost cutting also helped. Core administrative expenses fell by $2.9 million, R&D capex dropped 11% to $13.6 million, and permanent headcount reduced from 219 to 164. Normally, I would worry about whether cuts are simply short-term window dressing, but the company argues these savings come from integrating systems and simplifying operations after the DOCOMO Digital migration. That feels more credible.

Why did the statutory loss get worse if the business improved?

This is the awkward bit. Despite better margins and positive Cash EBITDA, Bango’s reported loss for the year widened to $7.6 million from $3.7 million. Basic loss per share moved to 9.86 cents from 4.75 cents.

The main reasons were higher depreciation and amortisation, higher finance costs, and $6.4 million of exceptional items. Amortisation alone rose to $12.9 million from $10.7 million, largely reflecting past investment in the DVM. Finance costs increased to $2.0 million from $0.8 million after refinancing and the new Cambridge office lease.

In other words, the underlying business improved, but the accounting charges were heavier. That does not mean the loss is irrelevant – it clearly matters – but it does mean investors need to separate operating progress from non-cash charges and one-off restructuring costs.

Bango balance sheet and cash flow: stronger funding, but net debt is still higher

The balance sheet is a mixed picture. On the positive side, Bango secured an enhanced loan facility from NHN and a new $15.0 million revolving credit facility with NatWest. That gives it more flexibility and should reduce short-term funding pressure.

On the less positive side, net debt increased to $9.2 million from $1.8 million. Operating cash flow also swung to an outflow of $8.2 million, compared with an inflow of $18.9 million in FY24, which the company says reflects timing effects, lower-margin route normalisation, and one-off transition costs.

So yes, funding is better arranged, but this is not a pristine balance sheet yet. Bango still needs its improving cash generation story to keep moving forward.

Bango FY26 outlook: strong Q1 growth, but delayed deals and geopolitical risk remain

The start to FY26 looks good. Q1 revenue was up 13% year-on-year and Adjusted EBITDA increased 39%. Bango also reported three new DVM customer wins, with one already contracted.

That is a strong start, but there are two caveats. First, the delayed Q4 FY25 DVM opportunities mentioned in January still have not been signed, although discussions are continuing in Q2. Second, the company flagged increased macroeconomic and geopolitical uncertainty following developments in the Middle East.

Management says this did not affect Q1, but it could slow customer processes and sales cycles. That feels like a fair warning rather than panic, and it is sensible not to ignore it.

My verdict on Bango’s FY25 results for retail investors

I think these results are more positive than negative. The headline revenue dip is not ideal, and the rise in net debt plus the wider statutory loss mean this is not a clean, simple bull case. But the more important trends are encouraging.

Bango is growing recurring revenue quickly, improving margins, tightening costs, and showing early evidence that the DVM can scale profitably. If that continues, the market is likely to care much more about ARR growth, retention and cash generation than about shrinking low-margin payments revenue.

The big question now is execution. Bango needs to keep converting its pipeline, turn more of that subscriptions growth into cash, and prove that delayed deals are delayed rather than lost. For now, FY25 looks like a genuine step forward – just not the finished article.